SaltCheck, Inc. is seeking to develop and commercialize a new patient salt intake monitoring system, not requiring the use of laboratory facilities. Regular monitoring of salt intake is an important factor in the control of hypertension and congestive heart failure. SaltCheck will be funding research to develop a technology to be marketed for use in doctor offices, clinics and for at-home use on a worldwide basis. .

The technology is based on research by Doctors Samuel J. Mann and Linda M. Gerber from the Weill Medical College of Cornell University of New York. Additional research is necessary to determine the efficacy and accuracy of technology.

.:: LATEST NEWS